292 related articles for article (PubMed ID: 31644995)
1. Generation of three iPSC lines from fibroblasts of a patient with Aicardi Goutières Syndrome mutated in TREX1.
Ferraro RM; Lanzi G; Masneri S; Barisani C; Piovani G; Savio G; Cattalini M; Galli J; Cereda C; Muzi-Falconi M; Orcesi S; Fazzi E; Giliani S
Stem Cell Res; 2019 Dec; 41():101580. PubMed ID: 31644995
[TBL] [Abstract][Full Text] [Related]
2. Establishment of three iPSC lines from fibroblasts of a patient with Aicardi Goutières syndrome mutated in RNaseH2B.
Ferraro RM; Masneri S; Lanzi G; Barisani C; Piovani G; Savio G; Cattalini M; Galli J; Cereda C; Muzi-Falconi M; Orcesi S; Fazzi E; Giliani S
Stem Cell Res; 2019 Dec; 41():101620. PubMed ID: 31678772
[TBL] [Abstract][Full Text] [Related]
3. [Establishment of induced pluripotent stem cell model of Aicardi-Goutières Syndrome mutated in TREX1].
Liu X; Zeng RH; Gao C; Wang YL; Zhu LL; Wang WJ
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Jun; 57(6):923-928. PubMed ID: 37357214
[TBL] [Abstract][Full Text] [Related]
4. Generation of three isogenic induced Pluripotent Stem Cell lines (iPSCs) from fibroblasts of a patient with Aicardi Goutières Syndrome carrying a c.2471G>A dominant mutation in IFIH1 gene.
Masneri S; Lanzi G; Ferraro RM; Barisani C; Piovani G; Savio G; Cattalini M; Galli J; Cereda C; Muzi-Falconi M; Orcesi S; Fazzi E; Giliani S
Stem Cell Res; 2019 Dec; 41():101623. PubMed ID: 31698194
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of the immune system in Aicardi-Goutières syndrome: another example in a TREX1-mutated patient.
Olivieri I; Cattalini M; Tonduti D; La Piana R; Uggetti C; Galli J; Meini A; Tincani A; Moratto D; Fazzi E; Balottin U; Orcesi S
Lupus; 2013 Sep; 22(10):1064-9. PubMed ID: 23918923
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory myopathy in a patient with Aicardi-Goutières syndrome.
Tumienė B; Voisin N; Preikšaitienė E; Petroška D; Grikinienė J; Samaitienė R; Utkus A; Reymond A; Kučinskas V
Eur J Med Genet; 2017 Mar; 60(3):154-158. PubMed ID: 28089741
[TBL] [Abstract][Full Text] [Related]
7. Generation of three induced pluripotent stem cell lines from individuals with Aicardi-Goutières syndrome caused by a c.3019G>A (p.G1007R) autosomal dominant pathogenic variant in ADAR1.
Garcia L; Gonzalez CD; Gagne A; McGuire JA; French D; Takanohashi A; Almad A; Vanderver A; Sase S
Stem Cell Res; 2024 Feb; 74():103299. PubMed ID: 38181636
[TBL] [Abstract][Full Text] [Related]
8. A nationwide survey of Aicardi-Goutières syndrome patients identifies a strong association between dominant TREX1 mutations and chilblain lesions: Japanese cohort study.
Abe J; Nakamura K; Nishikomori R; Kato M; Mitsuiki N; Izawa K; Awaya T; Kawai T; Yasumi T; Toyoshima I; Hasegawa K; Ohshima Y; Hiragi T; Sasahara Y; Suzuki Y; Kikuchi M; Osaka H; Ohya T; Ninomiya S; Fujikawa S; Akasaka M; Iwata N; Kawakita A; Funatsuka M; Shintaku H; Ohara O; Ichinose H; Heike T
Rheumatology (Oxford); 2014 Mar; 53(3):448-58. PubMed ID: 24300241
[TBL] [Abstract][Full Text] [Related]
9. Aicardi-Goutières syndrome with muscle involvement in early infancy.
Deigendesch N; Morales-Gonzalez S; Weschke B; Goebel HH; Schuelke M; Stenzel W
Neuropathol Appl Neurobiol; 2018 Dec; 44(7):737-742. PubMed ID: 29210089
[No Abstract] [Full Text] [Related]
10. Heterozygous TREX1 p.Asp18Asn mutation can cause variable neurological symptoms in a family with Aicardi-Goutieres syndrome/familial chilblain lupus.
Abe J; Izawa K; Nishikomori R; Awaya T; Kawai T; Yasumi T; Hiragi N; Hiragi T; Ohshima Y; Heike T
Rheumatology (Oxford); 2013 Feb; 52(2):406-8. PubMed ID: 22829693
[No Abstract] [Full Text] [Related]
11. Aicardi-Goutières syndrome protein TREX1 suppresses L1 and maintains genome integrity through exonuclease-independent ORF1p depletion.
Li P; Du J; Goodier JL; Hou J; Kang J; Kazazian HH; Zhao K; Yu XF
Nucleic Acids Res; 2017 May; 45(8):4619-4631. PubMed ID: 28334850
[TBL] [Abstract][Full Text] [Related]
12. Inherited or de novo mutation affecting aspartate 18 of TREX1 results in either familial chilblain lupus or Aicardi-Goutières syndrome.
Tüngler V; Silver RM; Walkenhorst H; Günther C; Lee-Kirsch MA
Br J Dermatol; 2012 Jul; 167(1):212-4. PubMed ID: 22356656
[No Abstract] [Full Text] [Related]
13. Aicardi-Goutières syndrome.
Crow YJ
Handb Clin Neurol; 2013; 113():1629-35. PubMed ID: 23622384
[TBL] [Abstract][Full Text] [Related]
14. Intracerebral large artery disease in Aicardi-Goutières syndrome with TREX1 mutation: a case report.
Wu CC; Peng SS; Lee WT
Neurol Sci; 2020 Nov; 41(11):3353-3356. PubMed ID: 32524323
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic variability of a TREX1 variant in Aicardi-Goutieres type 1 patients from the Indian subcontinent.
Abraham SSC; Yoganathan S; Koshy B; Oommen SP; Simon A; Mathai S; Korula S; Mathew L; Sathishkumar D; Jasper A; George R; Danda S
Eur J Med Genet; 2021 Sep; 64(9):104291. PubMed ID: 34303877
[TBL] [Abstract][Full Text] [Related]
16. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic variation in Aicardi-Goutières syndrome explained by cell-specific IFN-stimulated gene response and cytokine release.
Cuadrado E; Michailidou I; van Bodegraven EJ; Jansen MH; Sluijs JA; Geerts D; Couraud PO; De Filippis L; Vescovi AL; Kuijpers TW; Hol EM
J Immunol; 2015 Apr; 194(8):3623-33. PubMed ID: 25769924
[TBL] [Abstract][Full Text] [Related]
18. Generation of three induced pluripotent cell lines (iPSCs) from an Aicardi-Goutières syndrome (AGS) patient harboring a deletion in the genomic locus of the sterile alpha motif and HD domain containing protein 1 (SAMHD1).
Fuchs NV; Schieck M; Neuenkirch M; Tondera C; Schmitz H; Wendeburg L; Steinemann D; Elpers C; Rutsch F; König R
Stem Cell Res; 2020 Mar; 43():101697. PubMed ID: 32062129
[TBL] [Abstract][Full Text] [Related]
19. Generation of induced pluripotent stem cell lines from two patients with Aicardi-Goutières syndrome type 1 due to biallelic TREX1 mutations.
Hänchen V; Kretschmer S; Wolf C; Engel K; Khattak S; Neumann K; Lee-Kirsch MA
Stem Cell Res; 2022 Oct; 64():102895. PubMed ID: 36027857
[TBL] [Abstract][Full Text] [Related]
20. The TREX1 exonuclease R114H mutation in Aicardi-Goutières syndrome and lupus reveals dimeric structure requirements for DNA degradation activity.
Orebaugh CD; Fye JM; Harvey S; Hollis T; Perrino FW
J Biol Chem; 2011 Nov; 286(46):40246-54. PubMed ID: 21937424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
